Suppr超能文献

肥胖中的肝脏。

Liver in obesity.

作者信息

Braillon A, Capron J P, Hervé M A, Degott C, Quenum C

出版信息

Gut. 1985 Feb;26(2):133-9. doi: 10.1136/gut.26.2.133.

Abstract

We report on clinical, nutritional, and hepatic histological findings in 50 non-selected obese subjects (mean overweight +74%; range +21-138%). The pathogenesis of the liver damage was assessed with the help of multidimensional analysis of a number of clinical variables. According to the severity of the hepatic lesions, the patients have been ranged in five groups: O (normal liver) 10%; I (fatty liver) 48%; II (fatty hepatitis) 26%; III (fatty fibrosis) 8%; IV (fatty cirrhosis) 8%. The more severe changes (groups III and IV) were constantly associated with excessive alcohol intake. The multidimensional analysis was unable to find a relationship between obesity and the development of fibrosis and cirrhosis whereas it showed that: (a) there was a highly significant correlation between the daily ethanol intake and the degree of overweight, (b) severe fatty metamorphosis was significantly associated with the degree of overweight, the existence of diabetes mellitus, and the amount of alcohol and fat intake, (c) nutritional factors, in particular deficient protein intake, have only an accessory effect in the development of mild inflammation and fibrosis, (d) the consumption of potentially hepatotoxic drugs, very high in the obese (about five drugs per day) could have a role in the development of cirrhosis. In conclusion in our study, there was no evidence that obesity per se could result in severe liver damage.

摘要

我们报告了50名未经挑选的肥胖受试者的临床、营养和肝脏组织学检查结果(平均超重74%;范围为21%-138%)。借助对多个临床变量的多维度分析评估肝脏损伤的发病机制。根据肝脏病变的严重程度,将患者分为五组:O组(正常肝脏)10%;I组(脂肪肝)48%;II组(脂肪性肝炎)26%;III组(脂肪性纤维化)8%;IV组(脂肪性肝硬化)8%。更严重的病变(III组和IV组)常与过量饮酒有关。多维度分析未能发现肥胖与纤维化和肝硬化的发展之间存在关联,然而其显示:(a)每日乙醇摄入量与超重程度之间存在高度显著的相关性,(b)严重的脂肪变性与超重程度、糖尿病的存在以及酒精和脂肪摄入量显著相关,(c)营养因素,尤其是蛋白质摄入不足,在轻度炎症和纤维化的发展中仅起辅助作用,(d)肥胖者中潜在肝毒性药物的消耗量很高(每天约五种药物)可能在肝硬化的发展中起作用。总之,在我们的研究中,没有证据表明肥胖本身会导致严重的肝脏损伤。

相似文献

1
Liver in obesity.肥胖中的肝脏。
Gut. 1985 Feb;26(2):133-9. doi: 10.1136/gut.26.2.133.
3
Fatty liver hepatitis and cirrhosis in obese patients.肥胖患者的脂肪性肝炎和肝硬化
Am J Med. 1979 Nov;67(5):811-6. doi: 10.1016/0002-9343(79)90740-x.
4
[Pathogenesis, clinical aspects and development of fatty liver].
Dtsch Z Verdau Stoffwechselkr. 1985;45(3):111-6.
5
Morphological features in non-cirrhotic livers from patients with chronic alcoholism, diabetes mellitus or adipositas. A comparative study.
Acta Pathol Microbiol Scand A. 1978 Nov;86A(6):495-8. doi: 10.1111/j.1699-0463.1978.tb02075.x.
10
Obesity, diabetes mellitus, and liver fibrosis.肥胖症、糖尿病和肝纤维化。
Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G697-702. doi: 10.1152/ajpgi.00426.2010. Epub 2011 Feb 24.

引用本文的文献

7
Nonalcoholic fatty liver disease during valproate therapy.丙戊酸治疗期间的非酒精性脂肪性肝病
Eur J Pediatr. 2009 Nov;168(11):1391-4. doi: 10.1007/s00431-009-0927-y. Epub 2009 Jan 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验